Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.784
-0.007 (-0.23%)
Mar 17, 2025, 1:01 PM EDT - Market open
Cassava Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cost of Revenue | 6.49 | 2.05 | 1.63 | 24.81 | 3.05 | |
| Gross Profit | -6.49 | -2.05 | -1.63 | -24.81 | -3.05 | |
| Selling, General & Admin | 71.81 | 16.53 | 11.99 | 8.06 | 3.74 | |
| Research & Development | 63.15 | 87.37 | 66.4 | - | - | |
| Operating Expenses | 134.95 | 103.91 | 78.39 | 8.06 | 3.74 | |
| Operating Income | -141.45 | -105.96 | -80.02 | -32.87 | -6.79 | |
| Interest & Investment Income | 8.51 | 7.83 | 2.78 | 0.05 | 0.11 | |
| Other Non Operating Income (Expenses) | 108.59 | 0.91 | 1 | 0.43 | - | |
| EBT Excluding Unusual Items | -24.34 | -97.22 | -76.25 | -32.39 | -6.68 | |
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.35 | |
| Pretax Income | -24.34 | -97.22 | -76.25 | -32.39 | -6.33 | |
| Net Income | -24.34 | -97.22 | -76.25 | -32.39 | -6.33 | |
| Net Income to Common | -24.34 | -97.22 | -76.25 | -32.39 | -6.33 | |
| Shares Outstanding (Basic) | 46 | 42 | 40 | 39 | 26 | |
| Shares Outstanding (Diluted) | 47 | 42 | 40 | 39 | 26 | |
| Shares Change (YoY) | 11.14% | 4.30% | 2.02% | 50.95% | 49.93% | |
| EPS (Basic) | -0.53 | -2.32 | -1.90 | -0.82 | -0.24 | |
| EPS (Diluted) | -1.46 | -2.32 | -1.90 | -0.82 | -0.24 | |
| Free Cash Flow | -117.03 | -82.44 | -80.23 | -52.41 | -5.38 | |
| Free Cash Flow Per Share | -2.51 | -1.97 | -2.00 | -1.33 | -0.21 | |
| EBITDA | -140.31 | -104.43 | -78.72 | -32.33 | -6.77 | |
| D&A For EBITDA | 1.13 | 1.53 | 1.3 | 0.53 | 0.02 | |
| EBIT | -141.45 | -105.96 | -80.02 | -32.87 | -6.79 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.